SCHEMBL26280652

SCHEMBL26280652

O=c1c2cc(-c3ccc(Cl)cc3)nc(-c3cccnc3)c2ncn1[C@H]1CCOC1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MTOR P42345 2/20 0.41
ATM Q13315 2/20 0.39
ATR Q13535 2/20 0.39
KCNH2 Q12809 2/20 0.39
CLK1 P49759 1/20 0.36
DYRK1A Q13627 1/20 0.36
PDE4A P27815 1/20 0.36
ADORA2A P29274 1/20 0.36
ADORA1 P30542 1/20 0.36
CSNK1D P48730 1/20 0.36
CSNK1E P49674 1/20 0.36
TGFBR1 P36897 2/20 0.36
TGFBR2 P37173 2/20 0.36
PSD A5PKW4 3/20 0.35
SLC2A1 P11166 1/20 0.35
PDE1A P54750 1/20 0.35
PDE1B Q01064 1/20 0.35
MAPK11 Q15759 1/20 0.35
MAPK14 Q16539 1/20 0.35
PIK3CA P42336 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23416866 1.00 MTOR (0.41) MTORATMATRKCNH2CLK1
SCHEMBL26295815 0.88 KCNH2 (0.40) MTORATMATRKCNH2CLK1
SCHEMBL26295905 0.88 KCNH2 (0.40) MTORATMATRKCNH2CLK1
SCHEMBL26292469 0.87 KCNH2 (0.37) ATMATRKCNH2CLK1DYRK1A
SCHEMBL23925576 0.86 CLK1 (0.41) KCNH2CLK1DYRK1AADORA2AADORA1
SCHEMBL25463926 0.86 CLK1 (0.41) KCNH2CLK1DYRK1AADORA2AADORA1
SCHEMBL23925577 0.86 CLK1 (0.41) KCNH2CLK1DYRK1AADORA2AADORA1
SCHEMBL23950535 0.84 CLK1 (0.38) KCNH2CLK1DYRK1AADORA2AADORA1
SCHEMBL23950537 0.84 CLK1 (0.38) KCNH2CLK1DYRK1AADORA2AADORA1
SCHEMBL25463141 0.84 CLK1 (0.38) KCNH2CLK1DYRK1AADORA2AADORA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230295152-A1 PYRIDOPYRIMIDINONE DERIVATIVES AS AHR ANTAGONISTS SENDA BIOSCIENCES, INC. (US) 2023-09-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230295152-A1 PYRIDOPYRIMIDINONE DERIVATIVES AS AHR ANTAGONISTS AHR, ARNT, AIPL1 MTOR 2985/4885ATM 1062/4885ATR 1671/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.